These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 26352511)
1. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD; AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511 [TBL] [Abstract][Full Text] [Related]
2. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy. Bares SH; Smeaton LM; Xu A; Godfrey C; McComsey GA J Womens Health (Larchmt); 2018 Sep; 27(9):1162-1169. PubMed ID: 29608129 [TBL] [Abstract][Full Text] [Related]
3. Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010. Koethe JR; Jenkins CA; Lau B; Shepherd BE; Silverberg MJ; Brown TT; Blashill AJ; Anema A; Willig A; Stinnette S; Napravnik S; Gill J; Crane HM; Sterling TR; HIV Med; 2015 Oct; 16(9):572-7. PubMed ID: 25960080 [TBL] [Abstract][Full Text] [Related]
4. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. Brar I; Shuter J; Thomas A; Daniels E; Absalon J; J Acquir Immune Defic Syndr; 2007 May; 45(1):66-71. PubMed ID: 17245229 [TBL] [Abstract][Full Text] [Related]
5. Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada. Rebeiro PF; Abraham AG; Horberg MA; Althoff KN; Yehia BR; Buchacz K; Lau BM; Sterling TR; Gange SJ AIDS Patient Care STDS; 2017 Mar; 31(3):129-144. PubMed ID: 28282246 [TBL] [Abstract][Full Text] [Related]
6. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. Bourgi K; Jenkins CA; Rebeiro PF; Palella F; Moore RD; Altoff KN; Gill J; Rabkin CS; Gange SJ; Horberg MA; Margolick J; Li J; Wong C; Willig A; Lima VD; Crane H; Thorne J; Silverberg M; Kirk G; Mathews WC; Sterling TR; Lake J; Koethe JR; J Int AIDS Soc; 2020 Apr; 23(4):e25484. PubMed ID: 32294337 [TBL] [Abstract][Full Text] [Related]
7. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial. Guehi C; Badjé A; Gabillard D; Ouattara E; Koulé SO; Moh R; Ekouevi D; Ahibo H; N'Takpé JB; Menan GK; Deschamps N; Lecarrou J; Eholié S; Anglaret X; Danel C AIDS Res Ther; 2016; 13():12. PubMed ID: 26925155 [TBL] [Abstract][Full Text] [Related]
8. Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa. Brennan AT; Berry KM; Rosen S; Stokes A; Crowther NJ; George J; Raal F; Cassim N; Sanne I; Long L; Fox MP AIDS; 2019 Nov; 33(13):2049-2059. PubMed ID: 31577571 [TBL] [Abstract][Full Text] [Related]
9. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US. Antiretroviral Therapy Cohort Collaboration (ART-CC) Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571 [TBL] [Abstract][Full Text] [Related]
10. Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. Koethe JR; Jenkins CA; Lau B; Shepherd BE; Wester W; Rebeiro PF; Silverberg MJ; Thorne JE; Gill J; Mayor AM; Willig A; Bosch R; Horberg MA; Justice AC; Sterling TR; Moore RD; J Acquir Immune Defic Syndr; 2016 Oct; 73(2):197-204. PubMed ID: 27116044 [TBL] [Abstract][Full Text] [Related]
11. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Koethe JR; Jenkins CA; Shepherd BE; Stinnette SE; Sterling TR Clin Infect Dis; 2011 Nov; 53(9):952-60. PubMed ID: 21946189 [TBL] [Abstract][Full Text] [Related]
12. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. Amorosa V; Synnestvedt M; Gross R; Friedman H; MacGregor RR; Gudonis D; Frank I; Tebas P J Acquir Immune Defic Syndr; 2005 Aug; 39(5):557-61. PubMed ID: 16044007 [TBL] [Abstract][Full Text] [Related]
13. Obesity Among HIV-Infected Adults Receiving Medical Care in the United States: Data From the Cross-Sectional Medical Monitoring Project and National Health and Nutrition Examination Survey. Thompson-Paul AM; Wei SC; Mattson CL; Robertson M; Hernandez-Romieu AC; Bell TK; Skarbinski J Medicine (Baltimore); 2015 Jul; 94(27):e1081. PubMed ID: 26166086 [TBL] [Abstract][Full Text] [Related]
14. HIV infection and obesity: where did all the wasting go? Tate T; Willig AL; Willig JH; Raper JL; Moneyham L; Kempf MC; Saag MS; Mugavero MJ Antivir Ther; 2012; 17(7):1281-9. PubMed ID: 22951353 [TBL] [Abstract][Full Text] [Related]
15. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. Lee JS; Humes E; Hogan BC; Justice AC; Klein M; Gebo K; John Gill M; Silverberg MJ; Rebeiro P; Horberg M; Karris M; Rabkin C; Moore RD; Althoff KN; Lancet HIV; 2022 Mar; 9 Suppl 1():S2. PubMed ID: 35304844 [TBL] [Abstract][Full Text] [Related]
16. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Althoff KN; Buchacz K; Hall HI; Zhang J; Hanna DB; Rebeiro P; Gange SJ; Moore RD; Kitahata MM; Gebo KA; Martin J; Justice AC; Horberg MA; Hogg RS; Sterling TR; Cescon A; Klein MB; Thorne JE; Crane HM; Mugavero MJ; Napravnik S; Kirk GD; Jacobson LP; Brooks JT; Ann Intern Med; 2012 Sep; 157(5):325-35. PubMed ID: 22944874 [TBL] [Abstract][Full Text] [Related]
17. Body mass index, immune status, and virological control in HIV-infected men who have sex with men. Blashill AJ; Mayer KH; Crane HM; Grasso C; Safren SA J Int Assoc Provid AIDS Care; 2013; 12(5):319-24. PubMed ID: 23719237 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study. Boodram B; Plankey MW; Cox C; Tien PC; Cohen MH; Anastos K; Karim R; Hyman C; Hershow RC AIDS Patient Care STDS; 2009 Dec; 23(12):1009-16. PubMed ID: 19909168 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda. Nakatudde I; Katana E; Agnes Odongpiny EL; Nalugga EA; Castelnuovo B; Fowler MG; Musoke P AIDS Res Ther; 2024 Apr; 21(1):23. PubMed ID: 38637785 [TBL] [Abstract][Full Text] [Related]
20. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Antiretroviral Therapy Cohort Collaboration Lancet HIV; 2017 Aug; 4(8):e349-e356. PubMed ID: 28501495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]